Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Macrophage EV miR-660 Drives Breast Cancer Metastasis
2026-09-14
The reference study identifies a macrophage-to-tumor communication mechanism in which extracellular vesicles transfer miR-660 into breast cancer cells. By suppressing KLHL21 and releasing IKKβ/NF-κB p65 signaling, this cargo promotes invasion, migration, and metastatic spread, providing a mechanistic framework for studying tumor-associated macrophage biology.
-
Pazopanib and ATRX-Deficient Glioma Vulnerability
2026-09-14
ATRX loss may expose a therapeutic dependency on receptor tyrosine kinase signaling in high-grade glioma. This thought-leadership article explains how Pazopanib (GW-786034) can be evaluated as a multi-targeted research tool, connects angiogenesis inhibition with tumor-cell signaling, and offers a biomarker-aware framework for combination studies with temozolomide.
-
BRCA2, PARP1 Retention, and RAD51 Filament Protection
2026-09-13
The 2025 Nature study identifies a previously unrecognized mechanism by which BRCA2 protects homologous recombination: it limits PARP1 retention on resected DNA and preserves RAD51 filament stability during strand exchange. By combining biochemical reconstitution, single-molecule FRET, and cellular localization microscopy, the work clarifies why BRCA2 loss can increase sensitivity to PARP inhibition and provides a mechanistic framework for DNA repair deficiency targeting.
-
Preeclampsia-Associated UCMSC Senescence
2026-09-12
This 2025 Placenta study identifies cellular senescence, mitochondrial dysfunction, and cytoskeletal abnormalities in umbilical cord mesenchymal stem cells derived from preeclamptic pregnancies. By combining transcriptomics with phenotypic assays and dasatinib–quercetin treatment, the work suggests that senescence-related pathways may be actionable targets for improving UCMSC function.
-
Streptavidin-HyperFluor 647: Assay Workflow
2026-09-11
Streptavidin-HyperFluor 647 delivers a bright red-range readout for biotinylated antibodies, nucleic acids, and proteins across microscopy, flow cytometry, and FRET-oriented assays. This guide explains practical staining workflows, controls, optimization parameters, and when a biotin-free BmTyr proximity-labeling strategy is the better choice.
-
MLKL-Driven Lysosomal Permeabilization in Necroptosis
2026-09-11
The reference study identifies lysosomal membrane permeabilization as a critical downstream consequence of MLKL polymerization during necroptosis. Its time-resolved imaging, MLKL-domain experiments, and cathepsin B perturbation data connect necrosome signaling to lysosomal enzyme release and provide a framework for testing lysosomal contributions to regulated cell death.
-
Nonselective β-Blockade and Hematopoietic Recovery
2026-09-10
The reference study shows that nonselective β-adrenergic inhibitors, unlike the β1-selective inhibitor metoprolol, can delay hematopoietic regeneration after allogeneic transplantation in mice and humans. Its receptor-selective design links peripheral-nerve signaling with transplant outcomes and suggests that β-blocker class, transplant type, posttransplant chemotherapy, and graft-cell dose should be considered together.
-
DAF-2 Diacetate for Nitric Oxide Imaging
2026-09-10
DAF-2 diacetate, also called 4,5-Diaminofluorescein diacetate, is a cell-permeable fluorescent probe for NO-associated chemistry. Its intracellular deacetylation and fluorescence accumulation support live-cell nitric oxide imaging, while soybean nodule studies provide a testable biological context for investigating reactive nitrogen species during sulfur-dependent senescence.
-
Sulfamonomethoxine Toxicity in Five Aquatic Species
2026-09-09
Huang and colleagues compared acute and chronic sulfamonomethoxine toxicity across algae, cladocerans, and medaka, showing that microalgae were more sensitive than the tested cladocerans. The study provides endpoint-specific benchmarks for aquatic risk assessment and highlights why exposure duration, trophic position, and organism selection matter when evaluating aquaculture antibiotic residues.
-
Gamithromycin: From Ribosome to Respiratory Translation
2026-09-09
Gamithromycin, also known as ML-1709460, illustrates how mechanism, matrix effects, pulmonary exposure, and AUC24h/MIC modeling can be integrated into more predictive veterinary respiratory research.
-
Fluorescein TSA Fluorescence System Kit Workflow
2026-09-08
Build a sensitive, microscopy-ready workflow for mapping low-abundance proteins and transcripts in fixed cells and brain tissue. The Fluorescein TSA Fluorescence System Kit is especially useful for validating region- and age-dependent astrocyte signatures identified by single-nucleus sequencing, while its covalent signal deposition supports careful localization of subtle molecular differences.
-
DeferoxamineB: Designing Iron-Pathway Assays
2026-09-08
DeferoxamineB is more than an iron chelator: it is a useful mechanistic probe for separating iron-dependent redox effects from apoptosis, autophagy, ferroptosis, and cuproptosis. This guide translates recent metabolic intervention findings into practical assay design and interpretation.
-
Verapamil HCl: Applied Calcium-Channel Workflows
2026-09-07
Verapamil HCl enables controlled studies of calcium-dependent excitability, apoptosis, drug transport, and inflammatory signaling. This practical guide connects myeloma combination assays with arthritis inflammation models while highlighting controls that separate calcium-channel effects from transporter-mediated changes.
-
6-Thioguanine Nanoparticles: Study Findings
2026-09-07
The reference study investigated chitosan nanoparticle delivery of 6-thioguanine, alone or combined with curcumin, in breast and ovarian cancer cell models. Its findings suggest that nanoparticle formulation can improve sustained release and in vitro cytotoxic activity, while also highlighting the need for in vivo pharmacokinetic, toxicity, and efficacy studies.
-
MLN8237 (Alisertib) for Aurora A Assays
2026-09-05
MLN8237 (Alisertib) enables selective interrogation of Aurora A signaling across mitotic control, spindle organization, and apoptosis workflows. This guide connects practical cell-based assay design with aneugen-mechanism profiling, helping researchers distinguish Aurora A biology from broader mitotic kinase or tubulin effects.